By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Chitin is a naturally occurring polysaccharide that is found in the cell walls of some fungi and the exoskeletons of crustaceans such as shrimp, crabs, and lobsters. The polymer chitosan is likewise made from chitin. It is used in a wide variety of fields, including agriculture, food, and pharmaceuticals. Chitosan is a widely used material in the biomedical industry due to its biocompatibility and biodegradability.
It is important in wound dressings because it can aid in the encouragement of wound healing and the reduction of infections. Chitosan is also employed in tissue engineering and drug delivery systems. It is advantageous as a chelating agent in water filtration because it can connect to metal ions. Heavy metal pollution from industrial waste can be eliminated, improving the water.
Chitosan has been investigated as a potential component in biodegradable plastics and packaging materials as an environmentally acceptable alternative to traditional polymers. Since chitosan is a flexible and advantageous material for the environment, it has drawn a lot of interest from a variety of sectors searching for sustainable solutions. Chitosan is marketed as a weight loss supplement due to its ability to adhere to dietary lipids in the digestive system and reduce their absorption. But research into and debate about its effectiveness as a weight-loss tool continues. It is used in cosmetic and skincare products because of its moisturizing and film-forming properties. It can improve skin texture and act as a barrier.
The Malaysia Chitosan market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Medical technology business Axio Biosolutions focuses on biomaterials. Its initial product line, Axiostat, has USFDA and CE approval and rapidly stops bleeding. The home-grown first aid solution has served the Indian Armed Forces, BSF, NSG, paramilitary forces, hospitals, and emergency services not just in India but also around the world, preventing many deaths from hemorrhage and severe injuries. Axio is ready to further disrupt the wound care market with its next-generation Chitosan-based advance product line, MaxioCel. Patients with chronic wounds such pressure ulcers, diabetic foot ulcers, venous leg ulcers, cavity wounds, skin abrasions, donor sites, and post-operative surgical wounds should find comfort and quicker recovery thanks to the “first of its kind” solution.
